420 likes | 739 Views
ANTIMICROBIAL THERAPY. CHAPTER 13. Chemotherapeutic Agents. Antibiotics: bacteriocidal vs bacteriostatic Synthetic Drugs vs natural product. History. Ancient remedies Ehrlich Domagk Fleming. Properties of Antimicrobial Agents. Selective Toxicity Spectrum of Activity Narrow Broad.
E N D
ANTIMICROBIAL THERAPY CHAPTER 13
Chemotherapeutic Agents • Antibiotics: bacteriocidal vs bacteriostatic • Synthetic Drugs vs natural product
History • Ancient remedies • Ehrlich • Domagk • Fleming
Properties of Antimicrobial Agents • Selective Toxicity • Spectrum of Activity • Narrow • Broad
Drug Mechanisms of Action • Inhibition of Cell Wall Synthesis • Disruption of Cell Membrane Function
Drug Mechanisms of Action • Inhibition of Protein Synthesis • Inhibition of Nucleic Acid Synthesis • Antimetabolites
Side Effects • Toxicity • Allergy • Disruption of Microflora
Classes of antibiotics • Aminoglycosides • Tetracyclines • Sulfonamides • Quinolones • Polypeptides • B-lactams • Macrolides • Glycopeptides • Cephalosporins
aminoglycosides kanamycin, neomycin, amikacin Binds 30 S ribosome
tetracyclines Tetracycline, Doxycycline Binds 30 S ribosome
sulfanamides Sulfacetamide Trimethoprim Sulfamethizole Folate synthesis inhibition. They are competitive inhibitors of the enzyme
B-lactams Amoxicillin Carbenicillin Penicillin Ampicillin disrupt the synthesis of the peptidoglycan layer of bacterial cell walls.
quinolones inhibit the bacterial DNA gyrase or the topoisomerase IV enzyme
polypeptides Inhibits isoprenyl pyrophosphate bacitracin Polymyxin B Interacts with the bacterial cytoplasmic membrane, changing its permeability.
macrolides Azithromycin Clarithromycin Spectinomycin Erythromycin Binds to 50s ribosome
Glycopeptides Vancomycin- last resort drug inhibiting peptidoglycan synthesis
cephalosporins Cefaclor Cefalexin Ceftobiprole Cefotaxime Same mode of action as other beta-lactam antibiotics: disrupt the synthesis of the peptidoglycan layer of bacterial cell walls.
Resistance to Drugs • Chromosomal - Klebsiella B lactamases • Plasmid borne - ribosomal protein mutations
Mechanisms of Drug Resistance • Mutations in Target molecules • Alterations in membrane permeability • Enzyme development
Fig. 27-27 Phosphorylation -Lactamase Adenylation Penicillin Streptomycin Acetylation Chloramphenicol
Mechanisms of Drug Resistance • Enzyme Activity Changes • Alterations in Anabolic Pathways
Generations of Drugs • First/Second/Third Line Drugs • Cross Resistance
Limiting Drug Resistance • Effective Drug Concentrations • Simultaneous Drug Administration • Synergism - clavulanic acid • Antagonism - • Restricting Drug Prescriptions
Determining Microbial Sensitivities • Disk Diffusion Method • Dilution Method • Serum Killing Power • Automated Methods
Solubility Selective toxicity Stable toxicity level Allergenicity Tissue stability Resistance Acquisition Shelf Life Cost Ideal Antimicrobial Attributes
Antibacterials — Cell Wall Target • Penicillins
Antibacterials — Cell Wall Target • Cephalosporins • Carbapenems
Antibacterials — Cell Membrane Target • Polymyxins
Antibacterials — Protein Synthesis Inhibition • Aminoglycosides • Tetracyclines • Chloramphenicol • Macrolides Insert Fig. 13.13
Antibacterials — Nucleic Acid Synthesis Inhibition • Rifampin • Quinolones
Antibacterials — Antimetabolites • Sulfonamides • Isoniazid • Ethambutol • Nitrofurans
Antifungals • Imidazoles • Polyenes • Griseofulvin
Antifungals • Flucytosine • Tolnaftate • Terbinafine
Antivirals • Nucleotide analogs
Antivirals • Amantidine/Rimantidine • Interferons/Immunoenhancers
Antiprotozoan Drugs • Quinine/derivatives • Metronidazole • Pyrimethamine • Suramin
Antihelminthic Drugs • Niclosamide • Mebendazole • Ivermectin